Season 3 Episode 25
Today, we discuss the latest advancements in gynecological oncology presented at ASCO 2025, featuring insights from Dr. Prachi Bhave. The conversation covers significant trials including the TRUST tr…
Published on 2 months, 1 week ago
Season 3 Episode 24
In this episode, Dr. Janet Abrahm shares transformative insights from ASCO 2025, focusing on palliative care and supportive care in oncology. Topics discussed include the role of exercise in cancer s…
Published on 2 months, 2 weeks ago
Season 3 Episode 23
In this episode, Dr. Ned McNamee discusses the latest advancements in lung cancer treatment presented at ASCO 2025, focusing on significant studies such as the Phase 3 DeLLphi-304 study and Checkmate…
Published on 2 months, 2 weeks ago
Season 3 Episode 22
Today, we cover ASCO 2025 in the genitourinary space, specifically bladder and renal cancer. Dr. Enrique Grande, a renowned oncologist and Program and Clinical Research lead of MD Anderson Cancer Cen…
Published on 2 months, 2 weeks ago
Season 3 Episode 21
Today, we’re joined by Professor Anthony Joshua, head of Medical Oncology at St. Vincent’s Hospital, Sydney, and a global leader in prostate cancer and melanoma.
In this episode, Professor Joshua dis…
Published on 2 months, 3 weeks ago
Season 3 Episode 20
In this episode, we unpack game-changing insights from ASCO 2025 with a spotlight on breast cancer. Joining us is Dr. Adam Brufsky, a trailblazing oncologist and professor at the University of Pittsb…
Published on 2 months, 3 weeks ago
Season 3 Episode 19
In our second plenary episode, we're spotlighting two pivotal phase 3 trials: SERENA-6, which explores ctDNA-guided treatment with camizestrant to delay progression in HR-positive, HER2-negative adva…
Published on 2 months, 3 weeks ago
Season 3 Episode 18
This year, Michael and Josh bring you the American Society of Clinical Oncology (ASCO) 2025. To keep it fresh, we're doing things a little differently, but rest assured, we'll bring along a global ho…
Published on 3 months ago
Season 3 Episode 17
This week, we talk about metastatic bladder cancer. The last two years have seen drastic changes in this space, with the addition of immunotherapy and ADCs in a first-line setting. While exceptionall…
Published on 3 months, 1 week ago
Season 3 Episode 16
This week, we explore muscle-invasive bladder cancer (MIBC). This space has made significant progress with the completion of two pivotal trials. The first was VESPER, comparing two chemotherapy regim…
Published on 3 months, 2 weeks ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate